期刊文献+

岩藻多糖对高尿酸血症小鼠肠粘膜屏障功能保护作用 被引量:1

Fucoidan protects intestinal mucosal barrier function in hyperuricemic mice
原文传递
导出
摘要 目的探讨岩藻多糖对高尿酸血症模型小鼠肠黏膜屏障功能的保护作用及机制。方法采用40只C57BL/6J小鼠建立高尿酸血症模型,随机分为4组,分别为对照组、高尿酸血症模型组、岩藻多糖干预组、别嘌呤醇阳性对照组,每组10只。比色法测定小鼠血清尿酸(UA)水平,ELISA法检测脂多糖(LPS)、二胺氧化酶(DAO)以及肿瘤坏死因子(TNF-α)、白介素-1β(IL-1β)水平。小鼠回肠组织病理变化采用苏木精–伊红(HE)染色法进行观察,生物素示踪实验观察回肠组织通透性,蛋白印迹法测定小肠组织中紧密连接蛋白、自噬相关蛋白等的表达。结果与模型组比较,岩藻多糖使高尿酸血症模型小鼠的血清尿酸水平明显下降52.45%、TNF-α水平明显下降29.18%、IL-1β水平明显下降25.36%;与对照组比较,LPS水平明显降低27.24%、DAO水平明显降低21.78%(P<0.05),改善肠黏膜细胞通透性,增加ZO-l、occludin的表达水平(P<0.05)。与模型组相比,岩藻多糖组LC3BⅡ/Ⅰ比值及beclin-1蛋白表达水平明显升高(P<0.05);p38 MAPK表达水平明显增加(P<0.05),p-mTOR表达水平明显降低(P<0.01)。结论岩藻多糖降低高尿酸血症小鼠血清尿酸水平,并通过上调p38 MAPK/mTOR通路增强小肠黏膜细胞自噬水平,减轻肠黏膜屏障损伤。 Objective To investigate the protective effect and mechanism of fucoidan on intestinal mucosal barrier function in hyperuricemic mice.Methods Forty specific pathogen-free(SPF)C57BL/6J mice were randomly assigned into a control,hyperuricemia model,fucoidan treatment(by gavage administration at the dosage of 200 mg/kg/day continuously for 10 weeks),and allopurinol positive control group(10 in each group).By the end of the treatments for the mice of the four groups,serum uric acid(UA)was measured with colorimetric method;serum lipopolysaccharides(LPS),diamine oxidase(DAO),tumor necrosis factor(TNF-α)and interleukin-1β(IL-1β)were measured with enzymelinked immunosorbent assay(ELISA).Histopathological changes in ileum mucosa were observed with hematoxylin-eosin(HE)staining;the expressions of tight junction proteins in ileum mucosa and autophagy-related proteins in small intestine were determined with Western blot.Results Significant decreases in serum UA(52.45%),TNF-α(29.18%),IL-1β(25.36%),LPS(27.24%),and DAO(21.78%)were detected in the hyperuricemic mice with fucoidan treatment(P<0.05 for all);in addition,the fucoidan-treated hyperuricemic mice had significantly improved intestinal cell junctions and permeability,increased expressions of zonula occludens-1(ZO-l),occludin and autophagy-related proteins(all P<0.05).Compared to those in model mice,significantly increased ratio of autophagy-related proteins light chain 3B II/I(LC3BII/I),beclin-1,and phosphorylated p38 mitogen-activated protein kinase(p-p38 MAPK)but significantly decreased phosphorylated mammalian target of rapamycin(p-mTOR)were observed in the hyperuricemic mice with fucoidan treatment.Conclusion Oral administration of fucoidan could effectively reduce serum uric acid and improve intestinal mucosal barrier damage by increasing autophagy via p38 MAPK/mTOR pathway in hyperuricemic mice.
作者 曲瑞莲 李婧 张亚斌 张楠 薛美兰 梁惠 QU Ruilian;LI Jing;ZHANG Yabin;ZHANG Nan;XUE Meilan;LIANG Hui(School of Public Health,Qingdao University,Qingdao 266071,China;Qingdao Health School,Qingdao 266071,China;School of Basic Medicine,Qingdao University,Qingdao 266071,China)
出处 《中国公共卫生》 CAS CSCD 北大核心 2023年第9期1165-1170,共6页 Chinese Journal of Public Health
基金 国家自然科学基金(82273626) 山东省自然科学基金(ZR2020MH215)。
关键词 岩藻多糖 高尿酸血症 肠黏膜屏障 自噬 fucoidan hyperuricemia intestinal mucosal barrier autophagy
  • 相关文献

参考文献6

二级参考文献67

  • 1杨克新,王玉静.痛风和高尿酸血症的临床特点和护理[J].护士进修杂志,1995,10(8):5-6. 被引量:2
  • 2王海坤,韩代书.Toll样受体(TLRs)的信号转导与免疫调节[J].生物化学与生物物理进展,2006,33(9):820-827. 被引量:60
  • 3SoltaniZ, RasheedK KapustaDR, et al. Potential role of uric acid in metabolic syndrome, hypertension, kidneyinjury, and cardiovascular diseases:isittimeforreappraisal?[J]. Curr Hypertens Rep, 2013, 15(3):175-181.
  • 4Choi HK, Mount DB, Reginato AM. Pathogenesis of gout [J]. Ann Intern Med, 2005, 143(7):499-516.
  • 5Kannangara DR, Ramasamy SN, Indraratna PL, et al. Fractional clearance of urate:validation of measurement in spot-urine samples in healthy subjects and gouty patients[J]. Arthritis Res Ther, 2012, 14(4):R189.
  • 6Li LX, Wang AP, Zhang R, et al. Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for in hospital-based patients with type 2 diabetes:a cross-sectional study[J]. Cardiovasc Diabetol, 2015, 14:36.
  • 7Kaditis A, Gozal D, Snow AB, et al. Uric acid excretion in North American and Southeast European children with obstructive sleepapnea[J]. SleepMed, 2010, 11 (5):489-493.
  • 8Simkin PA. When, wh)5 and how should we quantify the excretion rate of urinary uric acid? [J]. JRheumatol, 2001, 28 (6): 1207-1210.
  • 9Juraschek SP, Miller ER, Gelber AC. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials[J]. Arthritis Care Res(Hoboken), 2011, 63(9):1295- 1306.
  • 10Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney[J]. Pediatr Nephrol, 2014, 29(6):999-1008.

共引文献37

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部